13F Data
13F filer · CIK 1599882

Rhenman & Partners Asset Management AB

Stockholm, V7 · filing since Q4 2013 · last filing Aug 13, 2026
Reported value
$1.1B
+$248.9M vs prior
Positions
99
New / sold out
21 / 8
Added / reduced
41 / 34
Turnover
17.7%
buys $331.2M · sells $165.9M
Top-10 weight
25.1%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASTRAZENECA PLC+151,500–+$28.5M
NewMERCK & CO INC+213,500–+$27.4M
AddedUNITED HEALTH GROUP INC+48,100+105.7%+$20.0M
NewJNJJOHNSON & JOHNSON+72,500–+$18.4M
NewCENTENE CORP DEL+244,000–+$15.7M
AddedDANAHER CORPORATION+62,200+344.6%+$11.8M
NewDEXCOM INC+160,000–+$10.8M
NewSPYRE THERAPEUTICS INC+119,300–+$10.6M
AddedALIGN TECHNOLOGY INC+55,500+740.0%+$9.4M
AddedNURIX THERAPEUTICS INC+370,750+118.3%+$9.0M
52 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedLLYLILLY ELI & CO-11,400-33.8%$-13.7M
ReducedREGENERON PHARMACEUTICALS-20,710-43.1%$-12.9M
ReducedVEEVA SYS INC-68,000-79.7%$-12.1M
Sold outADAPTIVE BIOTECHNOLOGIES COR-720,000-100.0%$-10.0M
Sold outIQVIA HLDGS INC-53,000-100.0%$-9.0M
ReducedMADRIGAL PHARMACEUTICALS INC-16,000-66.5%$-8.6M
Sold outNUVALENT INC-81,200-100.0%$-8.3M
ReducedOSCAR HEALTH INC-268,000-40.6%$-7.6M
ReducedBOSTON SCIENTIFIC CORP-174,500-27.9%$-7.4M
ReducedVERTEX PHARMACEUTICALS INC-12,800-29.4%$-6.4M
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $255.7MQ1 2014: $333.2MQ2 2014: $337.0MQ3 2014: $341.5MQ4 2014: $345.0MQ1 2015: $593.1MQ2 2015: $832.7MQ3 2015: $627.3MQ4 2015: $661.4MQ1 2016: $503.8MQ2 2016: $563.1MQ3 2016: $629.6MQ4 2016: $521.6MQ1 2017: $631.5MQ2 2017: $696.5MQ3 2017: $783.3MQ4 2017: $740.1MQ1 2018: $811.3MQ2 2018: $977.1MQ3 2018: $998.0MQ4 2018: $874.8MQ1 2019: $854.9MQ2 2019: $907.9MQ3 2019: $797.7MQ4 2019: $912.5MQ1 2020: $713.8MQ2 2020: $925.6MQ3 2020: $1.1BQ4 2020: $1.2BQ1 2021: $1.4BQ2 2021: $1.5BQ3 2021: $1.4BQ4 2021: $1.5BQ1 2022: $1.0BQ2 2022: $880.1MQ3 2022: $955.0MQ4 2022: $958.5MQ1 2023: $910.9MQ2 2023: $948.7MQ3 2023: $927.5MQ4 2023: $1.0BQ1 2024: $1.1BQ2 2024: $1.0BQ3 2024: $1.2BQ4 2024: $972.9MQ1 2025: $870.0MQ2 2025: $791.0MQ3 2025: $903.7MQ4 2025: $1.1BQ1 2026: $810.5MQ2 2026: $1.1B
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1UNITED HEALTH GROUP INCCOM93,600$38.9M3.67%
2CVSCVS HEALTH CORP279,374$28.9M2.73%
3ASTRAZENECA PLCORD151,500$28.5M2.69%
4MERCK & CO INCCOM213,500$27.4M2.59%
5LLYLILLY ELI & CO22,315$26.8M2.53%
6ABBVIE INCCOM96,775$24.4M2.30%
7ALIGNMENT HEALTHCARE INCCOM997,083$23.7M2.24%
8EDWARDS LIFESCIENCES CORPCOM260,000$23.5M2.22%
9GILEAD SCIENCES INCCOM178,250$22.5M2.13%
10JAZZ PHARMACEUTICALS PLCSHS USD87,440$21.1M1.99%
89 more rows. Subscribe for $29/month to see every row, download the data and use the API.